Their findings were consistent with our study showing that a high level of MDM2 expression (p = 0.002) is correlated with improved overall survival in HPV+ HNSCC patients compared to HPV- HNSCC patients (p = 0.263). This evidence concerns the gene MDM2 and head and neck squamous cell carcinoma.